Published in Ann Surg Oncol on January 23, 2014
Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol (2015) 1.06
Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis. Medicine (Baltimore) (2015) 1.00
Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma. Oncotarget (2016) 0.78
Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma. World J Surg (2017) 0.78
Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol (2016) 0.76
The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Oncotarget (2016) 0.75
Combined Fibrinogen and Neutrophil-Lymphocyte Ratio as a Prognostic Marker of Advanced Esophageal Squamous Cell Carcinoma. Cancer Sci (2016) 0.75
Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies. Sci Rep (2017) 0.75
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg (2003) 6.04
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol (2010) 4.83
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer (2004) 2.39
Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer (2006) 2.33
Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis (2007) 2.30
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol (2009) 2.26
Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg (2001) 1.90
R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg (2008) 1.88
Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg (1998) 1.88
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer (2005) 1.69
Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer (2007) 1.64
Update on colorectal cancer. Am Fam Physician (2000) 1.63
Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol (2009) 1.57
p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer (2004) 1.56
Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol (1997) 1.47
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.46
Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell (2007) 1.45
Resection for multiple metastatic liver tumors after portal embolization. Surgery (1994) 1.41
Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis (2010) 1.40
Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology (2006) 1.34
Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol (2008) 1.31
Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol (2010) 1.27
Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol (2009) 1.21
Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg (2009) 1.21
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer (2007) 1.21
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. Br J Cancer (2010) 1.18
Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer (2006) 1.11
The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol (2006) 1.10
Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet (2005) 1.10
The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg (2004) 1.08
Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer (2004) 1.05
The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer. Br J Cancer (2010) 1.02
Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg (2010) 0.94
Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg (2002) 0.94
Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Am J Surg (2008) 0.90
Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer. Ann Surg Oncol (2010) 0.90
Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases. J Surg Oncol (2009) 0.88
recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol (2011) 0.87
Role of hepatectomy in treating multiple bilobar colorectal cancer metastases. Surgery (2007) 0.86
Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg (2001) 0.82
Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases. World J Surg (2012) 0.79
Aggressive liver resection including major-vessel resection for colorectal liver metastases. World J Hepatol (2009) 0.78
Liver resection for colorectal metastases: the third hepatectomy. Ann Surg (2003) 2.57
High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival. Breast Cancer Res Treat (2013) 1.78
Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). J Cell Biochem (2014) 1.55
Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem (2003) 1.47
Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle (2012) 1.44
Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas. ANZ J Surg (2009) 1.44
Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle (2013) 1.41
Risk factors and management of bile leakage after hepatic resection. World J Surg (2003) 1.40
Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system. J Laparoendosc Adv Surg Tech A (2014) 1.40
The role of median sternotomy in resections for large hepatocellular carcinomas. Surgery (2005) 1.38
Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J (2002) 1.37
Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg (2010) 1.31
Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery (2004) 1.30
Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg (2004) 1.27
Application of the transorally inserted anvil (OrVil) after laparoscopy-assisted total gastrectomy. Surg Endosc (2010) 1.26
Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery (2008) 1.24
The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg (2012) 1.23
Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery (2007) 1.21
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2012) 1.16
Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer (2006) 1.16
Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own gene promoter through physical interaction with lymphoid-enhancing factor 1. J Biol Chem (2002) 1.12
Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg (2009) 1.12
Microphthalmia-associated transcription factor in the Wnt signaling pathway. Pigment Cell Res (2003) 1.12
Prognostic factors after resection of pancreatic cancer. World J Surg (2009) 1.11
Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg (2008) 1.06
Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells. Oncol Rep (2007) 1.05
A good model of hepatic failure after excessive hepatectomy in mice. J Surg Res (2005) 1.04
Mucin-producing gallbladder adenocarcinoma with focal small cell and large cell neuroendocrine differentiation associated with pancreaticobiliary maljunction. Pathol Int (2008) 1.02
Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg (2003) 0.99
Management of massive arterial hemorrhage after pancreatobiliary surgery: does embolotherapy contribute to successful outcome? J Gastrointest Surg (2007) 0.99
Prognostic significance of the number of positive lymph nodes in gallbladder cancer. J Gastrointest Surg (2006) 0.98
Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11. Anticancer Res (2010) 0.98
Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level. J Cell Biochem (2013) 0.97
Identification of a distal enhancer for the melanocyte-specific promoter of the MITF gene. Pigment Cell Res (2002) 0.97
Usefulness of absorbable sutures in preventing surgical site infection in hepatectomy. J Gastrointest Surg (2008) 0.97
Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. Cancer Sci (2011) 0.96
High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence. Ann Surg Oncol (2009) 0.96
Fluorescent proteins enhance UVC PDT of cancer cells. Anticancer Res (2012) 0.96
Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery (2006) 0.96
Mitf functions as an in ovo regulator for cell differentiation and proliferation during development of the chick RPE. Dev Biol (2008) 0.95
A systematic review of laparoscopic total gastrectomy for gastric cancer. Gastric Cancer (2015) 0.95
Rapid screening assay for KRAS mutations by the modified smart amplification process. J Mol Diagn (2008) 0.95
Hypoxemia and blunted hypoxic ventilatory responses in mice lacking heme oxygenase-2. Biochem Biophys Res Commun (2004) 0.95
Short-term results of a randomized study between laparoscopic and open surgery in elderly colorectal cancer patients. Surg Endosc (2014) 0.95
Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticancer Res (2010) 0.95
The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer. Int J Colorectal Dis (2013) 0.94
Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer. Clin Cancer Res (2008) 0.94
Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol (2007) 0.94
Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer. J Surg Oncol (2014) 0.94
Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg (2009) 0.93
Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg (2005) 0.93
Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer. Hepatogastroenterology (2005) 0.93
Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation. Surg Today (2011) 0.92
Hepatocellular carcinoma occurring in a young Crohn's disease patient. Pathol Int (2009) 0.91
Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci (2013) 0.90
The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg (2005) 0.90
The effectiveness and appropriate management of abdominal drains in patients undergoing elective liver resection: a retrospective analysis and prospective case series. Surg Today (2012) 0.90
Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci (2015) 0.90
Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm. World J Surg (2008) 0.90
MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Hepatogastroenterology (2005) 0.89
Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: an autopsy case. Hum Vaccin Immunother (2013) 0.89
Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis. Nutrition (2005) 0.89
Effect of obesity on laparoscopy-assisted distal gastrectomy compared with open distal gastrectomy for gastric cancer. J Surg Oncol (2010) 0.89
Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma. World J Surg (2004) 0.89
Outcome of and risk factors for incisional hernia after partial hepatectomy. J Gastrointest Surg (2008) 0.89